Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

Le discusses the implications of these new guidelines and whether the US healthcare system can manage the increasing public burden of hypertension.

Breaking Down 2025 ACC/AHA Hypertension Guidelines, with Viet Le, PA-C, DMSc

A review estimated that eliminating cerebrovascular disease could have prevented 1.5 to 1.8 million US dementia cases in 2020.


Eliminating Cerebrovascular Disease May Prevent One-Third of US Dementia Cases

Survey reveals persistent misconceptions about blood pressure thresholds, symptoms, and management, with most patients willing to act on clinician advice.

Knowledge Gaps on Hypertension Underscore Need for Clearer Clinician Guidance

The updated recommendations encourage both patients and clinicians to take a more proactive approach to preventing or managing hypertension.

AHA & ACC Release New Guidelines for High Blood Pressure to Reduce CVD Risk

Panelists discuss how improving adherence requires both individual strategies like smartphone reminders and smart medication monitoring devices, as well as population-level interventions including reducing sodium content in processed foods and harmonizing hypertension guidelines to address the epidemic of poorly controlled blood pressure.

Optimizing Patient Adherence and Targeting the Root Causes of Treatment Resistance 

Panelists discuss how newer therapies will likely be incorporated into guidelines with improved reimbursement structures over time, similar to the evolution seen with lipid-lowering medications, making advanced treatments more accessible for patients with uncontrolled blood pressure.

Integration of Newer Agents Into Future Guidelines

Over 11,000 bottles have been voluntarily recalled in response to a consumer complaint of a foreign substance inside a tablet, later identified as aluminum.

FDA, Sun Pharmaceuticals Issue National Recall of Spironolactone 25 mg Tablets

July delivered 9 impactful advancements across the gamut of disciplines in cardiology.

9 Cardiology Headlines You Missed in July 2025

Panelists discuss how follow-up strategies should include monthly visits initially with more frequent monitoring for high-risk situations, emphasizing home blood pressure monitoring and utilizing team-based care approaches with optimal visit intervals of 4 to 6 weeks to avoid both therapeutic inertia and overadjustment.

Lab Monitoring or Follow-Up Strategies With New Agents

Panelists discuss how shared decision-making requires explaining the rationale for blood pressure control, addressing patient fears about medications, and utilizing newer drug classes like endothelin receptor antagonists that offer a “clean slate” approach for patients who have had negative experiences with traditional therapies.

Shared Decision-Making With Patients Who Have Failed Multiple Agents

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.